Physician
Internal Medicine
Dr. Jeffery P. Struewing, MD
Doctor Jeffery P. Struewing, MD practices Internal Medicine. Jeffery Struewing is also a published doctor. He has 98 publication published. The most recent publication is: Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
Publications
- Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.
- Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
- Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.
- Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists.
- Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).
- Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists.
- Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists.
- BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.
- The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.
- Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
- Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
- BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
- Breast cancer risks for BRCA1/2 carriers.
- Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
- CHEK2:1100delC and female breast cancer in the United States.
- BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
- Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
- Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
- Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among e...
- Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
- A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
- Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.
- Association of ESR1 gene tagging SNPs with breast cancer risk.
- Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
- Quantitation of DNA in buccal cell samples collected in epidemiological studies.
- Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
- A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
- A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.
- Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
- Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
- Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
- A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
- Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
- Founder BRCA1/2 mutations among male patients with breast cancer in Israel.
- Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay.
- Re: Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.
- Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.
- The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
- Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
- Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
- The kin-cohort study for estimating penetrance.
- The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
- Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
- Tuberculosis infection among young adults entering the US Navy in 1990.
- Genetic epidemiology of epithelial ovarian cancer.
- Interpreting a single antistreptolysin O test: a comparison of the "upper limit of normal" and likelihood ratio methods.
- The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.
- Germline p16 mutations in familial melanoma.
- Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
- Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
- Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.
- The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
- Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM.
- Secular changes in case mix of SCI patients at Montebello.
- Predictors of rehabilitation outcome among patients with SCI.
- An epidemic of respiratory complaints exacerbated by mass psychogenic illness in a military recruit population.
- Sonographic studies of schoolchildren in a village endemic for Schistosoma mansoni.
- Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine.
- Improving colorectal cancer screening in a medical residents' primary care clinic.
- Oral erythromycin prophylaxis against Streptococcus pyogenes infection in penicillin-allergic military recruits: a randomized clinical trial.
- Seroprevalence of hepatitis A, B, and C in a United States military recruit population.
- Efficacy of hepatitis B vaccination in primary school children from a village endemic for Schistosoma mansoni.
- BRCA1 in special populations.
- Prospective risk of cancer in CDKN2A germline mutation carriers.
- Skewed X chromosome inactivation and early-onset breast cancer.
- The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
- Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965.
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
- The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
- BRCA1 mutations in young women with breast cancer.
- Prophylactic oophorectomy in inherited breast/ovarian cancer families.
- Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.
- Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women.
- A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
- XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk.
- Performance of high-throughput DNA quantification methods.
- Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.
- Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium.
- HapScope: a software system for automated and visual analysis of functionally annotated haplotypes.
- Genomic approaches to identifying breast cancer susceptibility factors.
- BRCA1 and sex ratio.
- Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
- Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.
- The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
- DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
- CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
- A common coding variant in CASP8 is associated with breast cancer risk.
- AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
- Genome-wide association study identifies novel breast cancer susceptibility loci.
- Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.
- Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
- RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
- The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in geno...
- FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
- Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.
- The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies.
- No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.
Schools
Indiana University School of Medicine
Doctors Specialties
- Preventive Public Health Medicine
- Internal Medicine
Accepted Insurances
Helpful Reviews
Similar Doctors
|
Dr. Ling Chin, MD |
|
|
Dr. Tina K. Khoie, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa A. Pearse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric R. Brodsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethan M. Shevach, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael A. Gnatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seema M. Jilani, MD
This Doctor is OpenDoctor Recommended.
|